1
|
Khammari A, Dinulescu M, Nguyen JM, Cassecuel J, Maillard H, Le Duff F, Machet L, Beylot-Barry M, Legoupil D, Wierzbicka-Hainaut E, Bedane C, Leccia MT, Debarbieux S, Meyer N, Monestier S, Bens G, Denis M, Vourch M, Bossard C, Vergier B, Dréno B. L’efficacité de l’imiquimod dans la prise en charge du mélanome de Dubreuilh in situ (lentigo malin). Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
2
|
Amatore F, Devey S, Tabelé C, Troin L, Monestier S, Malissen N, Gaudy‐Marqueste C, Grob J, Richard M. Comparison of complementary and alternative medicine use between patients with skin cancer and inflammatory skin diseases. J Eur Acad Dermatol Venereol 2020; 34:e182-e183. [DOI: 10.1111/jdv.16142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- F. Amatore
- Department of Dermatology and Oncodermatology Timone Hospital Marseille France
| | - S. Devey
- Department of Dermatology and Oncodermatology Timone Hospital Marseille France
| | - C. Tabelé
- Department of Pharmacy Timone Hospital Marseille France
| | - L. Troin
- Department of Dermatology and Oncodermatology Timone Hospital Marseille France
| | - S. Monestier
- Department of Dermatology and Oncodermatology Timone Hospital Marseille France
| | - N. Malissen
- Department of Dermatology and Oncodermatology Timone Hospital Marseille France
| | - C. Gaudy‐Marqueste
- Department of Dermatology and Oncodermatology Timone Hospital Marseille France
| | - J.‐J. Grob
- Department of Dermatology and Oncodermatology Timone Hospital Marseille France
| | - M.‐A. Richard
- Department of Dermatology and Oncodermatology Timone Hospital Marseille France
| |
Collapse
|
3
|
Guichard G, Malissen N, Amatore F, Monestier S, Richard MA, Gaudy-Marqueste C, Grob JJ. Syndromes de relargage cytokinique chez des patients traités pour un mélanome métastatique. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
4
|
Stein C, Jourde-Chiche N, Burtey S, Jacques Grob J, Monestier S, Richard MA, Gaudy C, Brunet P. Effets secondaires rénaux chez les patients traités par immunothérapie anti-PD1 pour un mélanome métastatique : analyse d’une cohorte de 239 patients. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
5
|
|
6
|
Guichard G, Grange F, Saiag P, Charles J, Dreno B, Guillot B, Lacour JP, Gaudy C, Monestier S, Hesse S, Khammari A, Visseaux L, Kramkimel N, Finet A, Picard A, Malissen N, Troin L, Magis Q, Richard MA, Grob JJ. Il n’y a pas de surtoxicité des BRAF-MEK inhibiteurs lorsqu’ils sont prescrits immédiatement après l’arrêt des anti-PD1. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
7
|
Monnier JC, Hubiche T, Barlogis V, Zandotti C, Richard MA, Macagno N, Boissy C, Hesse S, Monestier S, Gaudy-Marqueste C, Grob JJ, Mallet S. Deux cas d’hydroa vacciniforme associé à une infection à EBV : implication du système immunitaire. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.460] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
8
|
Berniolles P, Abed S, Macagno N, Monestier S, Mallet S, Gaudy-Marqueste C, Grob JJ, Richard MA, Malissen N. Éruption urticarienne annulaire et ecchymotique révélant une infection à Capnocytophaga. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.479] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
9
|
Monnier J, Morand JJ, Lota-Zunino I, Retornaz K, Richard MA, Rojat-Habib MC, Macagno N, Ranque S, Farinetti A, Hesse S, Monestier S, Gaudy-Marqueste C, Grob JJ, Mallet S. Maladie de Wegener chez une enfant mimant une teigne du cuir chevelu. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
10
|
Monnier J, Collet-Villette AM, Olmi X, Monestier S, Pelletier J, Mallet S, Hesse S, Gaudy-Marqueste C, Grob JJ, Richard MA. Prise en charge par laser de molluscum contagiosum génitaux profus apparus sous fingolimod. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.580] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
11
|
Malissen N, Magis Q, Macagno N, Monestier S, Troin L, Mallet S, Gaudy-Marqueste C, Grob JJ, Richard MA. Réactions granulomateuses sur tatouage sous anti-BRAF + anti-MEK révélatrices de fausses progressions. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.165] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
12
|
Tabélé C, Monestier S, Malissen N, Gaudy C, Mallet S, Correard F, Honoré S, Bertault-Peres P, Grob JJ, Richard MA. Intérêt des consultations pharmaceutiques de thérapies ciblées en onco-dermatologie. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
13
|
Herms F, Haudebourg L, Bagot M, Dalac S, Dutriaux C, Grob JJ, Guillot B, Jeudy G, Lambert J, Lebbé C, Mateus C, Meyer N, Monestier S, Mortier L, Poulalhon N, Prey S, Robert C, Vabres P, Mouri M, Basset-Seguin N. Carcinomes basocellulaires localement avancés traités par vismodégib : devenir des rémissions complètes après arrêt du traitement. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
14
|
Malissen N, Macagno N, Monestier S, Magis Q, Troin L, Mallet S, Gaudy-Marqueste C, Grob JJ, Richard MA. Localisation élective de lentigines sur des plaques de psoriasis : pigmentation kératinocytaire basale plutôt qu’effet secondaire des traitements. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
15
|
Devey S, Tabelé C, Troin L, Monestier S, Gaudy C, Magis Q, Malissen N, Grob JJ, Richard MA. Traitements alternatifs en dermatologie : enquête dans un service hospitalo-universitaire. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.563] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
16
|
Magis Q, Gaudy-Marqueste C, Beliard S, Basire A, Loundou A, Malissen N, Troin L, Monestier S, Richard MA, Grob JJ. Diabète et déséquilibre glycémique sous anti-PD1. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
17
|
Gaudy-Marqueste C, Dussouil AS, Carron R, Troin L, Malissen N, Loundou A, Monestier S, Mallet S, Richard MA, Régis JM, Grob JJ. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery. Eur J Cancer 2017; 84:44-54. [PMID: 28783540 DOI: 10.1016/j.ejca.2017.07.017] [Citation(s) in RCA: 56] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2017] [Revised: 06/16/2017] [Accepted: 07/11/2017] [Indexed: 01/04/2023]
Abstract
BACKGROUND Targeted therapy (TT) and immunotherapies (ITs) have dramatically improved survival in metastatic melanoma (MM). However, their efficacy on brain metastasis (BM) remains limited and poorly documented. PATIENTS AND METHODS Retrospective cohort of consecutive MM patients (pts) with BMs, all systematically upfront treated by Gamma-Knife (GK) at first BM and retreated in case of new BMs, from 2010 to 2015 at the time when ipilimumab BRAF ± MEK inhibitors and anti-PD1 were introduced in practice. Survival after 1st GK (OSGK1) according to prognostic factors and treatment. RESULTS Among 179 consecutive pts treated by GK, 109 received IT and/or TT after the 1st GK. Median OSGK1 was 10.95 months and 1- and 2-year survival rates were 49.5% and 27.4%, respectively, versus a median overall survival (OS) of 2.29 months (p < .001) in those who did not receive IT or TT. In pts who initially had a single BM, median OS and 1- and 2-year survival rates were 14.46 months, 66.7% and 43.4%, respectively; in pts with 2-3 BMs: 8.85 months, 46.4% and 31%, respectively; in pts with >3 BMs: 7.25 months, 37.2% and 11.9%, respectively. Multivariate analysis for OSGK1 confirmed that IT and TT were significantly and highly protective. Best OSGK1 was observed in BRAF-wild-type pts receiving anti-PD1 or in BRAF-mutated pts receiving BRAF-inhibitors and anti-PD1 (12.26 and 14.82 months, respectively). CONCLUSION In real-life MM pts with BMs, a strategy aiming at controlling BM with GK together with TT and/or TT seems to achieve unprecedented survival rates.
Collapse
Affiliation(s)
- C Gaudy-Marqueste
- Dermatology and Skin Cancers Department, UMR911 CRO2, Aix-Marseille University, APHM, Marseille, France
| | - A S Dussouil
- Dermatology and Skin Cancers Department, UMR911 CRO2, Aix-Marseille University, APHM, Marseille, France
| | - R Carron
- Department of Stereotaxic and Functional Neurosurgery, Gamma-knife Unit, Inserm U751, Aix-Marseille University, APHM, Marseille, France
| | - L Troin
- Dermatology and Skin Cancers Department, UMR911 CRO2, Aix-Marseille University, APHM, Marseille, France
| | - N Malissen
- Dermatology and Skin Cancers Department, UMR911 CRO2, Aix-Marseille University, APHM, Marseille, France
| | - A Loundou
- Public Health Department, Aix-Marseille University, APHM, Marseille, France
| | - S Monestier
- Dermatology and Skin Cancers Department, UMR911 CRO2, Aix-Marseille University, APHM, Marseille, France
| | - S Mallet
- Dermatology and Skin Cancers Department, UMR911 CRO2, Aix-Marseille University, APHM, Marseille, France
| | - M A Richard
- Dermatology and Skin Cancers Department, UMR911 CRO2, Aix-Marseille University, APHM, Marseille, France
| | - J M Régis
- Department of Stereotaxic and Functional Neurosurgery, Gamma-knife Unit, Inserm U751, Aix-Marseille University, APHM, Marseille, France
| | - J J Grob
- Dermatology and Skin Cancers Department, UMR911 CRO2, Aix-Marseille University, APHM, Marseille, France.
| |
Collapse
|
18
|
Monnier J, Tabélé C, Chaspoul F, Monestier S, Rojat-Habib MC, Gaudy-Marqueste C, Mallet S, Hesse S, Richard MA, Grob JJ. La spectrophotométrie de masse par torche à plasma permettant le diagnostic d’une métallose cutanée et ganglionnaire mimant une infection de prothèse. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
19
|
Malissen N, Monestier S, Mallet S, Huynh C, Gaudy C, Richard MA, Grob JJ. Deux cas de syndrome d’activation macrophagique sous traitement inhibant la voie PD-1/PD-L1 et rationnel physiopathologique. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.185] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
20
|
Amatore F, Macagno N, Loundou A, Baumstarck K, Monestier S, Malissen N, Gaudy C, Mallet S, Hesse S, Grob JJ, Richard MA. Facteurs de risque de récidive des carcinomes épidermoïdes du vertex : importance de la prise en charge initiale. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
21
|
Basset Seguin N, Poulalhon N, Saiag P, Monestier S, Bagot M, Guillot B, Robert C, Meyer N, Khammari A, Grange F, Dutriaux C, Dréno B. Fréquence des résistances au vismodegib dans une série de 207 patients atteints de carcinomes basocellulaires localement avancés. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
22
|
Amatore F, Clévy C, Gaudy-Marqueste C, Malissen N, Monestier S, Mallet S, Hesse S, Grob JJ, Richard MA. Prise en charge de la fièvre chez les patients traités par combinaison dabrafenib-trametinib pour un mélanome métastatique muté BRAF V600E/K. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
23
|
De Sainte Marie B, Mallet S, Gaudy-Marqueste C, Baumstarck K, Bentaleb N, Loundou A, Hesse S, Monestier S, Grob JJ, Richard MA. [Therapeutic failure in scabies: An observational study]. Ann Dermatol Venereol 2015; 143:9-15. [PMID: 26651923 DOI: 10.1016/j.annder.2015.10.588] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2014] [Revised: 03/06/2015] [Accepted: 10/20/2015] [Indexed: 11/17/2022]
Abstract
BACKGROUND Several sources suggest an escalation of scabies in France. AIM To describe a population of patients continuing to present with scabies despite multiple treatments in order to identify factors associated with persistence of infection. PATIENTS AND METHODS A descriptive cross-sectional study in adults and children consulting for persistent scabies despite at least one previous treatment. A standardized questionnaire explored potential sources of treatment failure. RESULTS Thirty-one patients were analyzed. Initial symptoms were noted to have started between two and 52 weeks earlier (mean: 19 weeks). The mean number of prior consultations with a general practitioner was 3.1 (0-10) and 1.7 with a dermatologist (0-7). The mean number of patients per household was 3.5 (1-9). At least one dose of oral ivermectin (maximum of 6 doses per household) was prescribed for 84 % of patients (29 % of whom were not fasted at the time). Further, 74 % of patients received at least one local application of esdepallethrin and piperonyl butoxide (maximum: 5 courses), four received benzyl benzoate and two received permethrin; however, 58 % did not reapply the substance after hand washing. All households bought the prescribed treatments despite the costs. Close contacts of patients were treated in 58 % of households. Decontamination of bedding and clothing was carried out properly in 90 % of households. DISCUSSION Persistence of infection appears to be linked to: (1) insufficient treatment of close contacts; (2) absence of a second treatment between days 7 and 14; (3) insufficient efficacy of the available treatments, doubtless due to multiple factors (intrinsic resistance of Sarcoptes, failure to repeat treatment, poor explanation of methods for dosing and application, and oral intake of treatments). Access to non-reimbursed treatments was not identified as a problem and decontamination of bedding and clothing was correctly performed in most cases. CONCLUSION Though certain fundamental aspects of scabies treatment must be better known, longer consultations and provision of efficacious treatments are also a priority.
Collapse
Affiliation(s)
- B De Sainte Marie
- UMR 911, Inserm CRO2, centre de recherche en oncologie biologique et oncopharmacologie, service de dermatologie, hôpital Timone, Assistance publique-Hôpitaux de Marseille, Aix-Marseille université, 264, rue Saint-Pierre, 13385 Marseille, France
| | - S Mallet
- UMR 911, Inserm CRO2, centre de recherche en oncologie biologique et oncopharmacologie, service de dermatologie, hôpital Timone, Assistance publique-Hôpitaux de Marseille, Aix-Marseille université, 264, rue Saint-Pierre, 13385 Marseille, France.
| | - C Gaudy-Marqueste
- UMR 911, Inserm CRO2, centre de recherche en oncologie biologique et oncopharmacologie, service de dermatologie, hôpital Timone, Assistance publique-Hôpitaux de Marseille, Aix-Marseille université, 264, rue Saint-Pierre, 13385 Marseille, France
| | - K Baumstarck
- Unité d'aide méthodologique à la recherche clinique, Assistance publique-Hôpitaux de Marseille, Marseille, France; EA 3279 « Qualité de vie concepts, usages et limites, déterminants », Aix-Marseille université, Marseille, France
| | - N Bentaleb
- UMR 911, Inserm CRO2, centre de recherche en oncologie biologique et oncopharmacologie, service de dermatologie, hôpital Timone, Assistance publique-Hôpitaux de Marseille, Aix-Marseille université, 264, rue Saint-Pierre, 13385 Marseille, France
| | - A Loundou
- Unité d'aide méthodologique à la recherche clinique, Assistance publique-Hôpitaux de Marseille, Marseille, France; EA 3279 « Qualité de vie concepts, usages et limites, déterminants », Aix-Marseille université, Marseille, France
| | - S Hesse
- UMR 911, Inserm CRO2, centre de recherche en oncologie biologique et oncopharmacologie, service de dermatologie, hôpital Timone, Assistance publique-Hôpitaux de Marseille, Aix-Marseille université, 264, rue Saint-Pierre, 13385 Marseille, France
| | - S Monestier
- UMR 911, Inserm CRO2, centre de recherche en oncologie biologique et oncopharmacologie, service de dermatologie, hôpital Timone, Assistance publique-Hôpitaux de Marseille, Aix-Marseille université, 264, rue Saint-Pierre, 13385 Marseille, France
| | - J-J Grob
- UMR 911, Inserm CRO2, centre de recherche en oncologie biologique et oncopharmacologie, service de dermatologie, hôpital Timone, Assistance publique-Hôpitaux de Marseille, Aix-Marseille université, 264, rue Saint-Pierre, 13385 Marseille, France
| | - M-A Richard
- UMR 911, Inserm CRO2, centre de recherche en oncologie biologique et oncopharmacologie, service de dermatologie, hôpital Timone, Assistance publique-Hôpitaux de Marseille, Aix-Marseille université, 264, rue Saint-Pierre, 13385 Marseille, France
| |
Collapse
|
24
|
Gaudy-Marqueste C, Clevy C, Dubois N, Monestier S, Préau Y, Mallet S, Richard MA, Valéro R, Grob JJ, Béliard S. Survenue d’un diabète fulminant sous pembrolizumab. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.484] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
25
|
Gaudy-Marqueste C, Bruneu Y, Wazaefi Y, Avril MF, Triller R, Thomas L, Monestier S, Hesse S, Pellacani G, Malvehy J, Richard MA, Fertil B, Grob JJ. Le signe du vilain petit canard a une forte sensibilité et réduit fortement le nombre de nævus suspects à biopsier. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
26
|
Sterling B, Gaudy-Marqueste C, Vitte J, Liabeuf V, Castelain M, Hesse S, Richard MA, Grob JJ, Monestier S, Mallet S. Intérêt de la tryptase comme marqueur de sévérité des symptômes cutanés d’activation mastocytaire dans la mastocytose cutanée de l’enfant. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
27
|
Dussouil AS, Gaudy-Marqueste C, Carron R, Monestier S, Mallet S, Hesse S, Loundou A, Berbis P, Richard MA, Regis JM, Grob JJ. Gamma-Knife dans la prise en charge des métastases cérébrales de mélanome à l’époque des nouvelles thérapies. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
28
|
Gaudy-Marqueste C, Magis Q, Mallet S, Grapperon C, Monestier S, Richard MA, Grob JJ. Diplégie faciale au cours du traitement adjuvant d’un mélanome par dabrafénib/trametinib. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.476] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
29
|
Amatore F, Monestier S, Gaudy-Marqueste C, Mallet S, Richard MA, Hesse S, Grob JJ. Profils de tolérance respectifs des BRAF inhibiteurs dans le mélanome métastatique muté V600. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.387] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
30
|
Gaudy-Marqueste C, Carron R, Delsanti C, Loundou A, Monestier S, Archier E, Richard MA, Regis J, Grob JJ. On demand Gamma-Knife strategy can be safely combined with BRAF inhibitors for the treatment of melanoma brain metastases. Ann Oncol 2014; 25:2086-2091. [PMID: 25057167 DOI: 10.1093/annonc/mdu266] [Citation(s) in RCA: 64] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND Both Gamma-Knife radiosurgery (GKRS) and BRAF inhibitors (BRAF-I) have been shown to be useful in melanoma patients with brain metastases (BMs), thus suggesting that it could be interesting to combine their respective advantages. However, cases of radiosensitization following conventional radiation therapy in BRAF-I treated patients have raised serious concerns about the real feasibility and risk/benefit ratio of this combination. PATIENTS AND METHODS Review by two independent observers of brain magnetic resonance imaging (MRI) follow-up pictures, and volume and edema quantifications, and survival assessment in all patients who had been treated by GKRS and BRAF-I at a single institution. RESULTS Among 53 GKRS carried out in 30 patients who ever received BRAF-I and GKRS, 33 GKRS were carried out in 24 patients while under BRAF-I treatment, from which only 4 with an interruption of BRAF-I. The 20 other GKRS were carried out in 15 patients (including 9 of the 24) before initiation of BRAF-I treatment. No case of radiation-induced necrosis and no scalp radiation dermatitis occurred. A >20% increase in volume was observed in 35 of the 263 BM treated by GKRS (13.3%), but only 3 clear-cut edemas and 3 hemorrhages were detected within 2 months after GKRS, and 4 edemas and 7 hemorrhages later. Neither the MRI features nor the incidence of the volume changes, hemorrhage and edema were deemed unexpected for melanoma BM treated by GKRS. Median survival from first GKRS under BRAF-I and first dose of BRAF-I were 24.8 and 48.8 weeks, respectively. CONCLUSION This series does not show immediate radiotoxicity nor radiation recall, in melanoma patients with BRAF-I whose BMs are treated by GKRS. Interrupting BRAF-I for stereotactic radiosurgery (SRS) of BM seems useless, although it is still advised for other radiation therapies. The potential benefit of combining SRS and BRAF-I can be safely tested.
Collapse
Affiliation(s)
| | - R Carron
- Department of Stereotaxic and Functional Neurosurgery, Gammaknife Unit, Inserm U751
| | - C Delsanti
- Department of Stereotaxic and Functional Neurosurgery, Gammaknife Unit, Inserm U751
| | - A Loundou
- Department of Public Health, Aix-Marseille University, APHM, Marseille, France
| | - S Monestier
- Department of Dermatology and Skin Cancers, UMR911 CRO2
| | - E Archier
- Department of Dermatology and Skin Cancers, UMR911 CRO2
| | - M A Richard
- Department of Dermatology and Skin Cancers, UMR911 CRO2
| | - J Regis
- Department of Stereotaxic and Functional Neurosurgery, Gammaknife Unit, Inserm U751
| | - J J Grob
- Department of Dermatology and Skin Cancers, UMR911 CRO2
| |
Collapse
|
31
|
Mallet S, Ranque S, Amatore F, Archier E, Gaudy C, Monestier S, Hesse S, Grob JJ, Richard MA. Investigation et gestion d’une épidémie de teigne à la crèche d’un hôpital. Ann Dermatol Venereol 2013. [DOI: 10.1016/j.annder.2013.09.252] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
32
|
Gaudy-Marqueste C, Carron R, Archier E, Mallet S, Monestier S, Richard MA, Grob JJ. Radiochirurgie stéréotaxique et B-RAF inhibiteurs dans les métastases cérébrales de mélanome. Ann Dermatol Venereol 2013. [DOI: 10.1016/j.annder.2013.09.083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
33
|
Gaudy-Marqueste C, Monestier S, Mallet S, Richard MA, Grob JJ. Évolution métastatique d’un carcinome spinocellulaire, chez un patient traité par vismodegib. Ann Dermatol Venereol 2013. [DOI: 10.1016/j.annder.2013.09.202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
34
|
Gaudy-Marqueste C, Levy-Bencheton A, Monestier S, Mallet S, Archier E, Ouafik L, Richard MA, Grob JJ. Carcinome épidermoïde vulvaire sous vemurafenib. Ann Dermatol Venereol 2013. [DOI: 10.1016/j.annder.2013.09.196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
35
|
Troin L, Monestier S, Archier E, Richard MA, Gaudy-Marqueste C, Levy-Bencheton A, Grob JJ. DRESS sous vemurafenib : une bonne indication du dabrafenib ? Ann Dermatol Venereol 2013. [DOI: 10.1016/j.annder.2013.09.292] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
36
|
Dussouil AS, Gaudy-Marqueste C, Tasei AM, Monestier S, Mallet S, Grob JJ, Richard MA. [Telangiectasia during amlodipine therapy]. Ann Dermatol Venereol 2013; 140:202-5. [PMID: 23466153 DOI: 10.1016/j.annder.2012.12.007] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2012] [Revised: 10/28/2012] [Accepted: 12/05/2012] [Indexed: 11/24/2022]
Abstract
BACKGROUND Calcium inhibitors are recommended as first-line treatment in hypertension. We report the development of telangiectasia on the trunk and upper limbs in a female patient on amlodipine (Amlor(®)) that subsided on treatment discontinuation. PATIENTS AND METHODS A 63-year-old woman consulted for numerous asymptomatic stellate telangiectasias on her upper trunk and shoulders, with sparing of the face. No Darier's sign was seen and clinical examination was otherwise normal. The patient had been treated with amlodipine (Amlor(®)) and a combination of bisoprolol and hydrochlorothiazide (Lodoz(®)) for 5years for essential hypertension. Laboratory tests, which included serum tryptase assay, were normal. Histological analysis showed a normal epidermis with dilated superficial dermal capillaries and no inflammatory infiltrate or dermal elastosis. Amlodipine was discontinued and replaced with ramipril (an ACE inhibitor). The other treatments were changed over and the telangiectasias regressed spontaneously within several months, with no relapse being seen at one year of follow-up. COMMENTS Reports of telangiectasia associated with calcium inhibitors most commonly involve the dihydropyridine family, of which amlodipine is a member. Inhibition of muscular contraction induced by this treatment results in vasodilatation, accounting for the associated antihypertensive properties, and this could play a role in telangiectasia formation. The literature contains reports of cases of photo-distributed telangiectasia, suggesting that as well as vasodilatation, calcium inhibitors may in certain cases cause abnormal sensitivity of blood vessels to ultraviolet radiation. The absence of facial lesions rules out the hypothesis of photo-induced lesions in our patient.
Collapse
Affiliation(s)
- A-S Dussouil
- UMR 911, Inserm centre de recherche en oncologie biologique et oncophamacologie CRO2, service de dermatologie, hôpital de la Timone, Aix-Marseille université, Assistance Publique des Hôpitaux de Marseille, 264, rue Saint-Pierre, 13385 Marseille cedex 05, France.
| | | | | | | | | | | | | |
Collapse
|
37
|
Grob JJ, Wazaefi Y, Gaudy-Marqueste C, Bruneu Y, Thomas L, Avril MF, Triller R, Monestier S, Hesse S, Pellacani G, Malvehy J, Richard MA, Fertil B. L’analyse comparative des nævi et le signe du vilain petit canard (partie 1) : capacité des dermatologues à percevoir des morphotypes dominants de nævus chez chaque individu. Ann Dermatol Venereol 2012. [DOI: 10.1016/j.annder.2012.10.495] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
38
|
Gaudy-Marqueste C, Monestier S, Franques J, Cantais E, Richard MA, Grob JJ. Neuropathie digestive, et polyradiculonévrite induite par l’ipilimumab. Ann Dermatol Venereol 2012. [DOI: 10.1016/j.annder.2012.10.475] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
39
|
Delaigue S, Gaudy-Marqueste C, Rojat-Habib MC, Monestier S, Mallet S, Grob JJ, Richard MA. Pustulose érosive de la face. Ann Dermatol Venereol 2012. [DOI: 10.1016/j.annder.2012.10.267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
40
|
Gaudy-Marqueste C, Levy-Bencheton A, Monestier S, Hesse S, Ouafik L, Richard MA, Grob JJ. Mélanome invasif sous vemurafenib. Ann Dermatol Venereol 2012. [DOI: 10.1016/j.annder.2012.10.483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
41
|
Carré T, Gaudy-Marqueste C, Monestier S, Mallet S, Albarel F, Brue T, Richard MA, Grob JJ. Hypophysite sous ipilimumab chez les patients atteints de mélanome. Ann Dermatol Venereol 2012. [DOI: 10.1016/j.annder.2012.10.101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
42
|
Gaudy-Marqueste C, Taséi AM, Monestier S, Grob JJ, Richard MA. Évolution érosive d’une porokératose au cours d’un traitement par inhibiteur de MEK. Ann Dermatol Venereol 2012. [DOI: 10.1016/j.annder.2012.10.484] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
43
|
Perret-Court A, Michel J, Richard MA, Mancini J, Monestier S, Giovanni A, Grob JJ. Mélanomes muqueux naso-sinusiens. Impacts de la localisation initiale et de la prise en charge thérapeutique sur la survie à partir d’une série de 35 cas. Ann Dermatol Venereol 2011. [DOI: 10.1016/j.annder.2011.09.136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
44
|
Bruneu-Avierinos Y, Monestier S, Tasei AM, Gaudy-Marqueste C, Grob JJ, Richard MA. Granulomes induits par des injections de leuproréline acétate (Enantone ®). Ann Dermatol Venereol 2011; 138:35-7. [DOI: 10.1016/j.annder.2010.08.025] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2010] [Revised: 07/23/2010] [Accepted: 08/30/2010] [Indexed: 11/30/2022]
|
45
|
Maza A, Renard L, Monestier S, Grob JJ, Richard MA. [Fever with skin rash and polyarthralgia in a genetically black-skinned woman]. Med Trop (Mars) 2008; 68:297-299. [PMID: 18689326] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
Adult onset Still's disease (AOSD) is a systemic disorder characterized by intermittent fever, evanescent rash, polyarthralgia or arthritis, and neutrophilic leucocytoclasis. Appearance of skin rash during fever episodes is the characteristic feature. An atypical form of AOSD with a fixed pigmented skin rash was described in 1994. Prognosis of the atypical form is thought to be more severe than that of the classic form. The purpose of this report is to describe the first case of atypical AOSD in a genetically black-skinned woman. Treatment required administration of high-dose systemic corticosteroids.
Collapse
Affiliation(s)
- A Maza
- Service de dermatologie, CHU Sainte Marguerite, Marseille.
| | | | | | | | | |
Collapse
|
46
|
Monestier S, Gaudy C, Gouvernet J, Richard MA, Grob JJ. Multiple senile lentigos of the face, a skin ageing pattern resulting from a life excess of intermittent sun exposure in dark-skinned caucasians: a case-control study. Br J Dermatol 2005; 154:438-44. [PMID: 16445772 DOI: 10.1111/j.1365-2133.2005.06996.x] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
BACKGROUND Different patterns of skin ageing can be described depending on the predominant lesions, i.e. wrinkles, laxity, atrophy, senile lentigos (SLs), etc. They may correspond to different epidemiological contexts. OBJECTIVES To identify and assess the epidemiological factors for a skin ageing pattern characterized by a high density of SLs on the face, or 'lentigo ageing pattern' (LAP). METHODS An age- and sex-matched case-control study was conducted in individuals aged between 60 and 80 years, comparing cases (n = 118) with a very high number of SLs on the face for their age, and controls (n = 118) with no or very few SLs for their age. The cases and controls were recruited in two hospitals. RESULTS In univariate and multivariate analysis, LAP was associated with skin types III and IV, with frequent sunburns, and with the part of the lifetime cumulative sun exposure which was received during vacations. Conversely, there was no link with the occupational and everyday exposures and the total cumulative exposure. LAP was associated with multiple solar lentigos of the upper back. No relationship was found with postmenopausal hormonal therapy, number of naevi, or freckles. CONCLUSIONS Different epidemiological factors may account for the different skin ageing patterns. LAP seems to develop preferentially in dark-skinned caucasians who have repeatedly received intermittent and intense sun irradiations throughout their life, and have often developed solar lentigos on the upper back earlier in life, whereas the 'prominent wrinkling' pattern is known to affect light-skinned people and smokers with a life excess of continuous exposure.
Collapse
Affiliation(s)
- S Monestier
- Department of Dermatology, Hôpital Ste Marguerite, Assistance Publique des Hôpitaux de Marseille and Research Unit LIMP EA 3291, Université de la Méditerranée, France
| | | | | | | | | |
Collapse
|
47
|
Collet Villette AM, Richard MA, Fourquet F, Monestier S, Gaudy C, Bonerandi JJ, Grob JJ. Traitement de la maladie de Hailey-Hailey par laser ablatif CO2. Ann Dermatol Venereol 2005; 132:637-40. [PMID: 16230912 DOI: 10.1016/s0151-9638(05)79410-2] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
INTRODUCTION Only ablative methods lead to long term remission of areas affected by Hailey-Hailey disease: excision/skin graft, cryosurgery, dermabrasion... The method using the CO2 laser is a recent addition in the management of this dermatitis. We report our experience with this technique in 4 patients. PATIENTS AND METHODS Carbon dioxide laser vaporization was proposed to 4 patients exhibiting Hailey-Hailey disease resistant to classical treatments. A test under local anesthesia was performed beforehand in all the patients. A 60 year-old man had an immediate reaction and refused to continue treatment. In the other 3 cases, the result of the test at 6 months was considered satisfactory. These patients were treated under general anesthesia in a single area of 50 to 70 cm2, and a half-body for comparison. The CO2 laser was used in pulse mode, with successive irradiations, until a homogenous, whitish-yellow aspect with first retraction was obtained. RESULTS Although the healing delays were long (a mean of 1 month) and required major analgesics over the first few days, the cosmetic results were satisfactory and no abnormal scarring was observed. After a median follow-up of 27 months, no relapse of the disease other than punctiform elements was noted. All the patients wanted treatment of the other remaining affected areas be continued. In 2 patients, CO2 laser vaporization permitted treatment of areas not easily accessible to other ablative methods (around the mouth, the anus and the vulva) with anatomy and normal function spared. DISCUSSION These results are globally good. Although the time to healing was long, the cosmetic and functional results were always satisfactory, without abnormal scarring. Moreover, in 2 of the patients, CO2 laser was able to treat areas inaccessible to other methods. The reason for the efficacy of ablative methods is debated. Re-epidermization with keratinocytes of appendices and not expressing the molecular defect, and the constitution of dermal cicatricial tissue, are two currently proposed hypotheses.
Collapse
|
48
|
Mallet S, Tasei AM, Saadallah S, Monestier S, Grob JJ, Richard MA. [Post traumatic mucosal ectopia of the eyelid]. Ann Dermatol Venereol 2005; 132:502-3. [PMID: 15988371 DOI: 10.1016/s0151-9638(05)79321-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Affiliation(s)
- S Mallet
- Service de Dermatologie, Hôpital Sainte-Marguerite, Université de la Méditerranée, Marseille
| | | | | | | | | | | |
Collapse
|
49
|
Monestier S, Richard MA, Rey AC, Djemli A, Choux R, Grob JJ. [Multiple papules of the trunk]. Ann Dermatol Venereol 2002; 129:1315-6. [PMID: 12514525] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/28/2023]
Affiliation(s)
- S Monestier
- Service de Dermatologie, CHU Sainte-Marguerite, 270, boulevard de Sainte-Marguerite, 13009 Marseille
| | | | | | | | | | | |
Collapse
|
50
|
Retornaz F, Monestier S, Richard MA, Seux V, Grob JJ, Soubeyrand J. [Ulceronecrotic purpura revealing Waldenström's macroglobulinemia]. Presse Med 2001; 30:1007. [PMID: 11433686] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/20/2023] Open
|